Publications by authors named "Junko Morii"

Claim this Profile
C
Cost-Effectiveness Analysis of a Bivalent RSVPreF Vaccine in Japanese Adults Aged 60 Years and Older.
Kosaku Komiya, Yoko Hirano, Kazumasa Kamei, Asuka Yoshida, Junko Morii

Infect Dis Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Finerenone for Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes from Japanese Payer Perspective.
Ataru Igarashi, Kenichi Ohara, Hiroyuki Matsuda, Junko Morii, Suchitra Jagannathan

Adv Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration and its Subtypes from the Societal and Patient Perspectives in Japan.
Yasuo Yanagi, Kanji Takahashi, Tomohiro Iida, Fumi Gomi, Hiroshi Onishi, Junko Morii

Ophthalmol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine for routine pediatric vaccination programs in Japan.
Masayoshi Shinjoh, Kanae Togo, Tomoyuki Hayamizu, Naohiro Yonemoto, Junko Morii

Expert Rev Vaccines· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan.
Yasuo Yanagi, Kanji Takahashi, Tomohiro Iida, Fumi Gomi, Junko Morii

Ophthalmol Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan.
Yasuo Yanagi, Kanji Takahashi, Tomohiro Iida, Fumi Gomi, Junko Morii

Ophthalmol Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis